{"title":"“In My Experience…15 Data Points To Better Evaluate Platelet Rich Plasma Kits And Protocols”","authors":"Don Buford, Nathan Sherman","doi":"10.60118/001c.118697","DOIUrl":null,"url":null,"abstract":"Platelet rich plasma (PRP) use in orthopedics is growing. Clinical research documenting effective outcomes for various conditions is fueling interest in PRP as a safe intervention for many soft tissue and joint pathologies in orthopedics. However, clinicians do not have a consistent means to evaluate PRP as a biologic drug and as a result interpreting clinical reports can be challenging. Additionally, clinicians often do not have the necessary information to fully evaluate PRP kits and protocols when deciding on how to best integrate this therapy into their practice. This paper defines 15 different metrics that can be used to quantify PRP and to compare PRP kits and protocols. Our goal is to provide a comprehensive framework that allows for the unbiased evaluation of PRP regardless of the kit or protocol used. By using these PRP metrics routinely, we can improve characterization PRP for research and clinical purposes.","PeriodicalId":298624,"journal":{"name":"Journal of Orthopaedic Experience & Innovation","volume":"56 32","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Orthopaedic Experience & Innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.60118/001c.118697","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Platelet rich plasma (PRP) use in orthopedics is growing. Clinical research documenting effective outcomes for various conditions is fueling interest in PRP as a safe intervention for many soft tissue and joint pathologies in orthopedics. However, clinicians do not have a consistent means to evaluate PRP as a biologic drug and as a result interpreting clinical reports can be challenging. Additionally, clinicians often do not have the necessary information to fully evaluate PRP kits and protocols when deciding on how to best integrate this therapy into their practice. This paper defines 15 different metrics that can be used to quantify PRP and to compare PRP kits and protocols. Our goal is to provide a comprehensive framework that allows for the unbiased evaluation of PRP regardless of the kit or protocol used. By using these PRP metrics routinely, we can improve characterization PRP for research and clinical purposes.